Evaluation of the Zilver PTX Drug | 合法醫療器材資訊網

2016年3月25日 — 5-Year Results of Zilver PTX Trial · Study Questions: What are the 5-year comparative outcomes of drug-eluting stents (DES) to standard ... Read More

由 MD Dake 著作 · 2016 · 被引用 334 次 — Background: This randomized controlled trial evaluated clinical durability of Zilver PTX, a paclitaxel-coated drug-eluting stent (DES), for ... Read More

由 MD Dake 著作 · 2020 · 被引用 28 次 — Zilver PTX RCT: Level 1, randomized controlled trial; Japan PMS studies: Level 3​, post-market surveillance study. Read More

由 M Bosiers 著作 · 2020 · 被引用 10 次 — Purpose: To report the 12-month results of a multicenter, prospective, randomized controlled trial to determine if the ZILVER PTX paclitaxel-eluting stent was ... Read More

The clinical trial is stratified by lesion length. The trial will be conducted in 2 phases, with Phase 1 enrolling patients with lesions less than 7 cm long. Phase 2 of ... Read More

2020年10月2日 — The Zilver PTX RCT had a unique trial design. The RCT included a primary and secondary randomization, as well as an opportunity for patients in ... Read More

A bold decision: The ZILVER PTX randomized controlled trial was designed from the start to include 5-year follow-up data that would determine not only long-term​ ... Read More

由 MD Dake 著作 · 2016 · 被引用 334 次 — The Zilver PTX RCT was a large randomized trial that now provides long-term, 5-​year results for endovascular treatment of patients with ... Read More

由 WA Gray 著作 · 2018 · 被引用 89 次 — In the global Zilver PTX Randomized Trial, patients who had primary treatment with a Zilver PTX stent had a higher 12-month primary patency rate ... Read More